News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tauriga Sciences Inc. (TAUG) Executes $1 Million Term Sheet With Institutional Investor Following The Company's MOU Signed With California's Leading Manufacturer Of Topical And Medicinal Cannabis Products


3/3/2014 8:51:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ANGELES, March 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license or acquisition agreements and the development of a proprietary technology platform in the nanorobotics space, has today announced the execution of a non-binding term sheet of up to $1,000,000 USD to fund, in part, the Company's previously announced proposed acquisition of California's leading manufacturer of topical and medicinal cannabis products ("the Cannabis Manufacturer"). The final terms between the Company and the institutional investor ("the investor") will be disclosed in a to-be-finalized binding agreement.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES